These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19031694)

  • 1. [Hantavirus mucosal vaccine through different mucosal with heat-labile enterotoxin B subunit as adjuvants].
    Cao SC; Li JD; Lu P; Liu F; Wang Q; Liu QZ; Zhang QF; Li C; An Q; Liang MF; Li DX
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Jun; 22(3):174-6. PubMed ID: 19031694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secretory expression and purification of recombinant Escherichia coli heat-labile enterotoxin B subunit and its applications on intranasal vaccination of hantavirus.
    Cao S; Zhang Y; Liu F; Wang Q; Zhang Q; Liu Q; Li C; Liang M; Li D
    Mol Biotechnol; 2009 Feb; 41(2):91-8. PubMed ID: 19089660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers.
    Stephenson I; Zambon MC; Rudin A; Colegate A; Podda A; Bugarini R; Del Giudice G; Minutello A; Bonnington S; Holmgren J; Mills KH; Nicholson KG
    J Virol; 2006 May; 80(10):4962-70. PubMed ID: 16641287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Th1-biased immunoadjuvant effect of the recombinant B subunit of an Escherichia coli heat-labile enterotoxin on an inactivated porcine reproductive and respiratory syndrome virus antigen via intranasal immunization in mice.
    Su F; Xu L; Xue Y; Li J; Fu Y; Yu B; Wang S; Yuan X
    J Vet Med Sci; 2019 Oct; 81(10):1475-1484. PubMed ID: 31527353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen.
    Verweij WR; de Haan L; Holtrop M; Agsteribbe E; Brands R; van Scharrenburg GJ; Wilschut J
    Vaccine; 1998 Dec; 16(20):2069-76. PubMed ID: 9796066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant.
    Holmgren J; Bourgeois L; Carlin N; Clements J; Gustafsson B; Lundgren A; Nygren E; Tobias J; Walker R; Svennerholm AM
    Vaccine; 2013 May; 31(20):2457-64. PubMed ID: 23541621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B subunit of E. coli enterotoxin as adjuvant and carrier in oral and skin vaccination.
    Fingerut E; Gutter B; Goldway M; Eliahoo D; Pitcovski J
    Vet Immunol Immunopathol; 2006 Aug; 112(3-4):253-63. PubMed ID: 16701905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An adenovirus vectored mucosal adjuvant augments protection of mice immunized intranasally with an adenovirus-vectored foot-and-mouth disease virus subunit vaccine.
    Alejo DM; Moraes MP; Liao X; Dias CC; Tulman ER; Diaz-San Segundo F; Rood D; Grubman MJ; Silbart LK
    Vaccine; 2013 Apr; 31(18):2302-9. PubMed ID: 23499593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of inactivated Escherichia coli enterotoxins to enhance respiratory mucosal adjuvanticity during vaccination in swine.
    Barrette RW; Szczepanek SM; Rood D; Challa S; Avery N; Vajdy M; Kramer E; Rodriguez L; Silbart LK
    Clin Vaccine Immunol; 2011 Nov; 18(11):1996-8. PubMed ID: 21918121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of recombinant Lactobacillus casei-expressing F4 (K88) fimbrial adhesin FaeG in conjunction with a heat-labile enterotoxin A (LTAK63) and heat-labile enterotoxin B (LTB) of enterotoxigenic Escherichia coli as an oral adjuvant in mice.
    Yu M; Qi R; Chen C; Yin J; Ma S; Shi W; Wu Y; Ge J; Jiang Y; Tang L; Xu Y; Li Y
    J Appl Microbiol; 2017 Feb; 122(2):506-515. PubMed ID: 27860074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B subunit of Escherichia coli heat-labile enterotoxin as adjuvant of humoral immune response in recombinant BCG vaccination.
    da Silva Ramos Rocha A; Conceição FR; Grassmann AA; Lagranha VL; Dellagostin OA
    Can J Microbiol; 2008 Aug; 54(8):677-86. PubMed ID: 18772930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient extracellular production of recombinant Escherichia coli heat-labile enterotoxin B subunit by using the expression/secretion system of Bacillus brevis and its mucosal immunoadjuvanticity.
    Kozuka S; Yasuda Y; Isaka M; Masaki N; Taniguchi T; Matano K; Moriyama A; Ohkuma K; Goto N; Udaka S; Tochikubo K
    Vaccine; 2000 Mar; 18(17):1730-7. PubMed ID: 10699320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced mucosal immunogenicity of prion protein following fusion with B subunit of Escherichia coli heat-labile enterotoxin.
    Yamanaka H; Ishibashi D; Yamaguchi N; Yoshikawa D; Nakamura R; Okimura N; Arakawa T; Tsuji T; Katamine S; Sakaguchi S
    Vaccine; 2006 Apr; 24(15):2815-23. PubMed ID: 16446015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuated Escherichia coli strains expressing the colonization factor antigen I (CFA/I) and a detoxified heat-labile enterotoxin (LThK63) enhance clearance of ETEC from the lungs of mice and protect mice from intestinal ETEC colonization and LT-induced fluid accumulation.
    Byrd W; Boedeker EC
    Vet Immunol Immunopathol; 2013 Mar; 152(1-2):57-67. PubMed ID: 23122616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutants of type II heat-labile enterotoxin LT-IIa with altered ganglioside-binding activities and diminished toxicity are potent mucosal adjuvants.
    Nawar HF; Arce S; Russell MW; Connell TD
    Infect Immun; 2007 Feb; 75(2):621-33. PubMed ID: 17118982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic tobacco expressed HPV16-L1 and LT-B combined immunization induces strong mucosal and systemic immune responses in mice.
    Hongli L; Xukui L; Ting L; Wensheng L; Lusheng S; Jin Z
    Hum Vaccin Immunother; 2013 Jan; 9(1):83-9. PubMed ID: 23108357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the immunogenicity of a transgenic tobacco plant expressing the recombinant fusion protein of GP5 of porcine reproductive and respiratory syndrome virus and B subunit of Escherichia coli heat-labile enterotoxin in pigs.
    Chia MY; Hsiao SH; Chan HT; Do YY; Huang PL; Chang HW; Tsai YC; Lin CM; Pang VF; Jeng CR
    Vet Immunol Immunopathol; 2011 Apr; 140(3-4):215-25. PubMed ID: 21277027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant Norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responses.
    Guerrero RA; Ball JM; Krater SS; Pacheco SE; Clements JD; Estes MK
    J Virol; 2001 Oct; 75(20):9713-22. PubMed ID: 11559804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immune response of two microbial antigens delivered intradermally, sublingually, or the combination thereof.
    Lee S; Picking WL; Tzipori S
    Microbes Infect; 2014 Sep; 16(9):796-803. PubMed ID: 25111827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salmonella enterica serovar enteritidis ghosts carrying the Escherichia coli heat-labile enterotoxin B subunit are capable of inducing enhanced protective immune responses.
    Jawale CV; Lee JH
    Clin Vaccine Immunol; 2014 Jun; 21(6):799-807. PubMed ID: 24671556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.